129 related articles for article (PubMed ID: 8658640)
1. Daily serum inflammatory cytokine (tumor necrosis factor-alpha, interleukin-6) monitoring in liver transplantation focusing on allograft rejection: a five-case report.
Kita Y; Iwaki Y; Noguchi K; Tzakis AG; Todo S; Fung JJ; Starzl TE
Transplant Proc; 1996 Jun; 28(3):1237-40. PubMed ID: 8658640
[No Abstract] [Full Text] [Related]
2. Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts.
Kita Y; Iwaki Y; Noguchi K; Griffith BP; Tzakis AG; Todo S; Fung JJ; Starzl TE
Transplant Proc; 1996 Jun; 28(3):1229-34. PubMed ID: 8658638
[No Abstract] [Full Text] [Related]
3. Serum levels of interleukin-6, tumor necrosis factor-alpha, and interleukin-2 in rejecting human small bowel allografts.
Noguchi K; Yoshida Y; Yagihashi A; Kita Y; Takenaka T; Terasawa K; Hayashi S; Konno A; Kobayashi M; Nakamura K
Transplant Proc; 1992 Jun; 24(3):1152. PubMed ID: 1604565
[No Abstract] [Full Text] [Related]
4. Serial measurements of interleukin-6, interleukin-8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients.
George JF; Kirklin JK; Naftel DC; Bourge RC; White-Williams C; McGiffin DC; Savunen T; Everson MP
J Heart Lung Transplant; 1997 Oct; 16(10):1046-53. PubMed ID: 9361247
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of plasma levels of tumour necrosis factor alpha and interleukin-6 as rejection markers in a cohort of 142 heart-grafted patients followed by endomyocardial biopsy.
Abdallah AN; Billes MA; Attia Y; Doutremepuich C; Cassaigne A; Iron A
Eur Heart J; 1997 Jun; 18(6):1024-9. PubMed ID: 9183597
[TBL] [Abstract][Full Text] [Related]
6. Clinical and immunological aspects of liver allograft rejection.
Schlitt HJ
Transplant Proc; 1996 Feb; 28(1):514-6. PubMed ID: 8644333
[No Abstract] [Full Text] [Related]
7. Monitoring of plasma endothelin in relation to Doppler signal in human liver transplantation.
Rudy T; Hartwig T; Fritschka E; Erhard J; Eigler FW
Transplant Proc; 1993 Aug; 25(4):2658-61. PubMed ID: 8356712
[No Abstract] [Full Text] [Related]
8. Serial ultrasensitive CRP measurements may be useful in rejection diagnosis after kidney transplantation.
Oyen O; Wergeland R; Bentdal O; Hartmann A; Brekke IB; Stokke O
Transplant Proc; 2001 Jun; 33(4):2481-3. PubMed ID: 11406220
[No Abstract] [Full Text] [Related]
9. Rejection of human liver allografts: immuno-histopathologic relationship and direct allorecognition of donor antigens by T lymphocytes.
Arvieux C; Drouet C; Pasquier D; Zarski JP; Barnoud D; Granger P; Delannoy P; Letoublon C
Transplant Proc; 1996 Oct; 28(5):2849-50. PubMed ID: 8908097
[No Abstract] [Full Text] [Related]
10. An experimental model of rat liver allograft rejection monitored with FNAB.
Martelius T; Mäkisalo H; Höckerstedt K; Taskinen E; Lautenschlager I
Transplant Proc; 1995 Dec; 27(6):3550-1. PubMed ID: 8540097
[No Abstract] [Full Text] [Related]
11. Histopathology of hepatic allograft rejection after living-related liver transplantation.
Sageshima J; Fuchinoue S; Hashimoto E; Koike T; Abe M; Nakajima I; Tanaka K; Agishi T
Transplant Proc; 1998 Nov; 30(7):3214-5. PubMed ID: 9838421
[No Abstract] [Full Text] [Related]
12. Experience in therapy of chronic liver allograft rejection.
Charco R; Ruiz C; Allende E; Balsells J; Lazaro JL; Murio E; Bilbao I; Gifre E; Margarit C
Transplant Proc; 1995 Aug; 27(4):2293-4. PubMed ID: 7652811
[No Abstract] [Full Text] [Related]
13. Significance of IL-2, IL-2R, IL-6, and TNF-alpha as a diagnostic test of acute rejection after renal transplantation.
Cho WH; Kim HT; Sohn CY; Park CH; Park SB; Kim HC
Transplant Proc; 1998 Nov; 30(7):2967-9. PubMed ID: 9838310
[No Abstract] [Full Text] [Related]
14. Prognostic value of eosinophils for therapeutic response in severe acute hepatic allograft rejection.
Ben-Ari Z; Dhillon AP; Garwood L; Rolles K; Davidson B; Burroughs AK
Transplant Proc; 1996 Dec; 28(6):3624-8. PubMed ID: 8962399
[No Abstract] [Full Text] [Related]
15. Monoclonal anti-tumor necrosis factor-alpha antibody suppresses rejection, but enhances infectious complications in rat liver allograft recipients.
Shiraishi M; Shaked A; Yasunaga C; Hasuike Y; Imagawa DK; Busuttil RW
Transplant Proc; 1993 Feb; 25(1 Pt 1):128-9. PubMed ID: 8438250
[No Abstract] [Full Text] [Related]
16. Serum and urine IL-6 and TNF-alpha in renal transplant recipients with graft dysfunction.
Newstead CG; Lamb WR; Brenchley PE; Short CD
Transplantation; 1993 Oct; 56(4):831-5. PubMed ID: 8212202
[TBL] [Abstract][Full Text] [Related]
17. Refractory acute rejection in a living related liver transplantation.
Noritomi T; Sugawara Y; Kaneko J; Matsui Y; Makuuchi M
Hepatogastroenterology; 2003; 50(54):2192-3. PubMed ID: 14696495
[TBL] [Abstract][Full Text] [Related]
18. Intra-allograft production and systemic release of tumor necrosis factor-alpha: detection upon reperfusion.
Kalb TH; Walter M; Mayer L; Acarli K; Fukuzawa K; Schwanz ME; Miller CM
Transplant Proc; 1993 Apr; 25(2):1817-8. PubMed ID: 8470177
[No Abstract] [Full Text] [Related]
19. Distinct intragraft cytokine gene expression patterns during acute hepatic rejection under cyclosporine versus FK 506 primary immunosuppression.
Gaweco AS; Otto G; Otto HF; Geisse T; Hofmann WJ
Transplant Proc; 1994 Dec; 26(6):3111-3. PubMed ID: 7527948
[No Abstract] [Full Text] [Related]
20. The role of tumor necrosis factor in allograft rejection.
Zhu ZG; Asahara T; Yahata H; Ono E; Marubayashi S; Watanabe H; Fukuda Y; Dohi K
Hiroshima J Med Sci; 1993 Dec; 42(4):129-35. PubMed ID: 8014063
[No Abstract] [Full Text] [Related]
[Next] [New Search]
